Presentations
Mainstage Presentations 2025
MCCS Good Practice Guide
Professor Mike Barnes outlines essential clinical standards for safe and effective medical cannabis prescribing, including MDT peer approval, consultation protocols, prescribing criteria, and communication requirements for UK clinics.
Cannabis Health Symposium 2025
Download Slides →The Value of Real World Evidence in Cannabis Medicine
Dr Anne Katrin Schlag examines how real-world evidence from Project Twenty21 and paediatric epilepsy case series complements limited RCT data, highlighting the role of CBMPs in psychiatric disorders and severe treatment-resistant epilepsy.
Cannabis Health Symposium 2025
Download Slides →Exploring the Endocannabinoid System (ECS)
Dr Rowan Thompson delivers a deep dive into the endocannabinoid system, covering CB1/CB2 receptor biology, the wider eCBome, diet–ECS interactions, ECS dysfunction patterns, and the therapeutic implications for cannabinoids like THC and CBD across multiple conditions.
Cannabis Health Symposium 2025
Download Slides →The Role of the Pharmacist
Zul Mamon explores the frontline clinical and pharmaceutical challenges within medical cannabis, including safe prescribing pathways, pharmacist responsibilities, product quality assurance, patient counselling, risk mitigation, and the operational realities of dispensing CBMPs in the UK.
Cannabis Health Symposium 2025
Download Slides →Exploring the Evidence Base – ‘CBPMs in Psychiatry & Neurodiversity’
Dr Niraj Singh reviews the clinical and research evidence for cannabis-based medicines across anxiety, PTSD, ADHD, autism, OCD, and complex mental health presentations. The talk highlights targeted benefits (e.g., nightmares in PTSD, anxiety and agitation in ASD), limitations in ADHD and OCD trials, real-world findings, and detailed case studies demonstrating stabilisation through balanced oil regimens and reduced flower use.
Cannabis Health Symposium 2025
Download Slides →The Production of Prescription Cannabis
Dr Callie Seaman explains how prescription-grade cannabis is produced, covering plant anatomy, chemovars, trichomes, cannabinoid and terpene biosynthesis, cultivation stress responses, extraction methods, and the critical role of GACP/GMP standards in creating consistent, high-quality medical products.
Cannabis Health Symposium 2025
Download Slides →Cannabis-Based Medicines in Chronic Pain
Professor Mike Barnes reviews the evidence for CBMPs in chronic pain, covering efficacy across neuropathic, post-surgical, cancer, arthritic and headache pain, the analgesic roles of THC, CBD and minor cannabinoids, the importance of chemovars and full-spectrum products, optimal dosing ranges, opioid-sparing effects, safety data, and recent cost-effectiveness findings showing substantial potential NHS savings.
Cannabis Health Symposium 2025
Download Slides →Medical Cannabis & Driving: Guidance for Prescribers and Patients
Robert Jappie outlines the legal framework around driving while using CBMPs, explaining impairment and blood-level offences, prescribed-drug defences under Section 5(3), THC thresholds, roadside testing procedures, issues with joint smoking invalidating the defence, and practical risks patients face when prescriptions are older than two months.
Cannabis Health Symposium 2025
Download Slides →Beyond the Benefits: Risks, Side-Effects & Contraindications of CBPMs
Dr Jennifer Forbes provides a comprehensive, clinician-focused overview of the risks associated with CBPMs, including neurological and cognitive impairment, THC-related anxiety and paranoia, GI issues such as CHS, cardiovascular risks, drug–drug interactions via CYP pathways, and clear absolute and relative contraindications. The session highlights practical prescribing frameworks, case examples, informed consent, monitoring strategies, and harm-reporting guidance.
Cannabis Health Symposium 2025
Download Slides →Cannabinoid Medicines in Women’s Health
Dr Dani Gordon presents an in-depth overview of how cannabinoid medicines support women’s health across the reproductive lifespan. Topics include ECS involvement in menstrual regulation, perimenopause symptom management, endometriosis pain pathways, PMDD and cyclical mood disorders, neurodivergent women’s health, and integrative treatment strategies combining cannabinoids with HRT, functional medicine, nervous-system regulation and personalised prescribing frameworks.
Cannabis Health Symposium 2025
Download Slides →